Phentolamine mesylate

Cat. No.: 0225LY-1221

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Phentolamine mesylate is a nonselective alpha-adrenergic antagonist used for treating hypertensive emergencies, pheochromocytoma, Raynaud's disease, and various peripheral vascular conditions.

Synonym: Phentolamine methanesulfonate; Phentolamine mesilate; 65-28-1; Phentolamine (mesylate); OraVerse; Regitine mesylate; Phentolamine methanesulfonate salt; Regitin methanesulphonate; Regitine methanesulfonate; Mesylate phentolamine; Phentolamine methanesulphonate; 3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(p-tolyl)amino)phenol methanesulfonate; Phenol,3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-,monomethanesulfonate (salt); m-(N-(2-Imidazolin-2-ylmethyl)-p-toluidino)phenol monomethanesulfonate (salt); Phenol, 3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(4-methylphenyl)amino)-, monomethanesulfonate (salt)

CAS No.: 65-28-1

Compound CID: 91430

Formula: C₁₇H₁₉N₃O·CH₄O₃S

Formula Weight: 377.46

Specification

Targets&IC50: α-adrenoceptor: 5 - 30 nM

Relative Density: 1.2256 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Phentolamine mesylate can be used in pharmacological research to investigate the reversible blockade of both alpha-1 and alpha-2 adrenergic receptors.